VRTX Target $200 & NVDQ Target $50
VRTX for Cystic Fibrosis
NVDQ's PILLAR announced Zero leaks for surgeries
Key point: "based on PINPOINT images, made seven revisions to their operative plan in six patients (9.1%), and that the leak rate was zero percent."
Sentiment: Strong Buy